Evaluation of the development, implementation and the cost assesment of intravenous to oral therapy conversion

Asian Journal of Pharmaceutical and Health Sciences,2023,13,4,2891-2897.
Published:April 2024
Type:Research Article
Authors:
Author(s) affiliations:

Dr. K. Jagadeesh1,*, A. Aliza Naushin2, M. Alisha Tabassum3, B. Sowmya Sree4, Dr. K. Murali Mohan5

1Assistant Professor, Department of Pharmacy Practice, St. Johns college of pharmaceutical sciences, Yemmiganur, Kurnool, Andhra Pradesh, India.

2,3,4 Pharm.D Intern, Department of Pharmacy Practice, St. Johns college of Pharmaceutical Sciences, Yemmiganur, Kurnool, Andhra Pradesh, India. 5cardiologists, Adoni, Kurnool, Andhra Pradesh, India.

Abstract:

Aim: This study reports the results of a prospective observational study of Intravenous to oral conversion based on the duration of hospital stay, and cost assessments (in terms of patient benefit or savings, from the study) Methodology: A total of 101 patients including both the genders were suffering with different diseases were enrolled in a prospective observational study for a period of 6 months in the primary care hospital. The subjects had been considered into study based on the source of data, inclusion & exclusion criteria. Results: All 101 (100%) patients experienced a significant better difference in their medication therapy or treatment therapy and their duration of hospital stay and cost of illness was reduced. The duration of hospital stay was decreased from 6 days to 2 days and the cost savings were observed i.e., about 90-100% of cost saving was done to the higher number of the patient. Conclusion: Our prospective observational study, using a standard protocol and guidelines were decreases the cost of the therapy and duration of hospital stay to the patient. Thenumbers of conversions were more after the study performed.

EVALUATION OF THE DEVELOPMENT, IMPLEMENTATION AND THE COST ASSESSMENT OF INTRAVENOUS TO ORAL THERAPY CONVERSION